Stock CC THE CHEMOURS COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Chemours Company

Equities

CC

US1638511089

Diversified Chemicals

Market Closed - Nyse
Other stock markets
 04:00:01 2024-05-01 pm EDT 		5-day change 1st Jan Change
26 USD -2.80% Intraday chart for The Chemours Company -3.99% -17.56%
May. 01 Trans Mountain Pipeline's C$34-Billion Expansion Project Enters Commercial Service MT
May. 01 Transcript : The Chemours Company, Q1 2024 Earnings Call, May 01, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,958 4,078 5,469 4,621 4,682 3,983 - -
Enterprise Value (EV) 1 6,175 6,999 7,767 7,134 7,517 6,979 6,896 6,930
P/E ratio -56.5 x 18.8 x 9.32 x 8.39 x -19.7 x 16 x 7.41 x 4.92 x
Yield 5.53% 4.03% 2.98% 3.27% - 3.82% 4.07% 4.52%
Capitalization / Revenue 0.54 x 0.82 x 0.86 x 0.68 x 0.78 x 0.68 x 0.62 x 0.61 x
EV / Revenue 1.12 x 1.41 x 1.22 x 1.05 x 1.25 x 1.19 x 1.07 x 1.05 x
EV / EBITDA 6.05 x 7.96 x 5.92 x 5.24 x 7.41 x 8.3 x 5.77 x 5.13 x
EV / FCF 36.5 x 13 x 14.3 x 16 x 40.4 x -32.4 x 25.5 x 13.1 x
FCF Yield 2.74% 7.72% 6.99% 6.27% 2.47% -3.09% 3.92% 7.61%
Price to Book 4.29 x 5.03 x 5 x 4.11 x 6.36 x 4.64 x 3.41 x 2.34 x
Nbr of stocks (in thousands) 163,501 164,496 162,961 150,918 148,438 148,895 - -
Reference price 2 18.09 24.79 33.56 30.62 31.54 26.00 26.00 26.00
Announcement Date 2/13/20 2/11/21 2/10/22 2/9/23 3/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,526 4,969 6,345 6,794 6,027 5,879 6,427 6,574
EBITDA 1 1,020 879 1,313 1,361 1,014 840.5 1,195 1,351
EBIT 1 709 559 996 1,070 707 508.8 880 1,006
Operating Margin 12.83% 11.25% 15.7% 15.75% 11.73% 8.65% 13.69% 15.3%
Earnings before Tax (EBT) 1 - - - 741 - 305 657 986
Net income 1 -52 - 608 578 -238 247 532 799
Net margin -0.94% - 9.58% 8.51% -3.95% 4.2% 8.28% 12.15%
EPS 2 -0.3200 1.320 3.600 3.650 -1.600 1.620 3.510 5.280
Free Cash Flow 1 169 540 543 447 186 -215.3 270 527.3
FCF margin 3.06% 10.87% 8.56% 6.58% 3.09% -3.66% 4.2% 8.02%
FCF Conversion (EBITDA) 16.57% 61.43% 41.36% 32.84% 18.34% - 22.59% 39.02%
FCF Conversion (Net income) - - 89.31% 77.34% - - 50.75% 66%
Dividend per Share 2 1.000 1.000 1.000 1.000 - 0.9932 1.059 1.174
Announcement Date 2/13/20 2/11/21 2/10/22 2/9/23 3/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,575 1,764 1,915 1,777 1,338 1,536 1,643 1,487 1,361 1,350 1,542 1,530 1,457 1,523 1,679
EBITDA 1 307 403 475 363 120 304 324 247 176 193 220 225.4 202.1 271.8 349.2
EBIT 1 231 329 403 291 46 225 246 171 102 122 144 149.4 125.1 211.5 271.4
Operating Margin 14.67% 18.65% 21.04% 16.38% 3.44% 14.65% 14.97% 11.5% 7.49% 9.04% 9.34% 9.76% 8.59% 13.89% 16.16%
Earnings before Tax (EBT) 1 - - 231 299 - 173 -433 - -71 67 117 115 57 113 209
Net income 1 233 234 201 240 -97 145 -376 - -18 52 95 93 46 91 169
Net margin 14.79% 13.27% 10.5% 13.51% -7.25% 9.44% -22.88% - -1.32% 3.85% 6.16% 6.08% 3.16% 5.98% 10.07%
EPS 2 1.400 1.430 1.260 1.520 -0.6500 0.9600 -2.520 - -0.1200 0.3400 0.6200 0.6100 0.3000 0.5900 1.090
Dividend per Share 2 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 0.2500 - - 0.2483 0.2483 0.2483 0.2689 0.2705
Announcement Date 2/10/22 5/2/22 7/28/22 10/25/22 2/9/23 4/27/23 7/28/23 10/26/23 3/27/24 4/30/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,217 2,921 2,298 2,513 2,835 2,996 2,913 2,947
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.154 x 3.323 x 1.75 x 1.846 x 2.796 x 3.565 x 2.438 x 2.181 x
Free Cash Flow 1 169 540 543 447 186 -215 270 527
ROE (net income / shareholders' equity) 49.2% 43.8% 64.2% 67.5% 46.1% 33.7% 50.7% 46.8%
ROA (Net income/ Total Assets) 5.73% 4.59% 8.31% 9.72% 5.35% 3.85% 5.57% 6.75%
Assets 1 -907.2 - 7,316 5,948 -4,449 6,412 9,548 11,844
Book Value Per Share 2 4.210 4.930 6.710 7.450 4.960 5.600 7.620 11.10
Cash Flow per Share 2 3.940 - 4.860 4.760 3.690 0.5000 2.060 4.800
Capex 1 481 267 277 307 370 412 447 403
Capex / Sales 8.7% 5.37% 4.37% 4.52% 6.14% 7.01% 6.95% 6.13%
Announcement Date 2/13/20 2/11/21 2/10/22 2/9/23 3/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for The Chemours Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
26.75 USD
Average target price
31.27 USD
Spread / Average Target
+16.90%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
THE CHEMOURS COMPANY Stock The Chemours Company
-17.56% 3.98B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
+2.65% 78.54B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+1.79% 30.31B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+12.30% 18.58B
BRENNTAG SE Stock Brenntag SE
-10.05% 11.56B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+5.50% 11.11B
SYENSQO SA/NV Stock Syensqo SA/NV
-7.50% 9.81B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
+6.40% 9.69B
SRF LIMITED Stock SRF Limited
+5.61% 9.3B
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
+6.40% 8.33B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. CC Stock
  4. Financials The Chemours Company